Communicators

are winners!

More News

03.07.2025
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors’ Conference Call
28.06.2025
Onco-Innovations Welcomes AstraZeneca’s Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
26.06.2025
Onco-Innovations’ CEO to Host Special Investors’ Conference Call on Wednesday, July 2, 2025
21.06.2025
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
14.06.2025
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
06.06.2025
Onco-Innovations’ Inka Health to Launch Global AI-Oncology Consortium to Advance Predictive Cancer Research
27.05.2025
Onco-Innovations Announces Start of Manufacturing of Preclinical Testing Material for Its PNKP Inhibitor Technology by Dalton Pharma
23.05.2025
Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology
17.05.2025
Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
25.04.2025
Onco-Innovations’ Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science